New review article on mHSPC and mCRPC


Below you will find a link to a valuable new review article on ongoing changes in the opportunities for evaluation and management of men with both hormone-sensitive and castration-resistant, metastatic prostate cancer (mHSPC and mCRPC).

This new article by Aggarwal et al. (“Emerging categories of disease in advanced prostate cancer and their therapeutic implications“) is probably a very valuable resource for patients with newly diagnosed and/or progressive forms of metastatic prostate cancer, as well as for support group leaders and other prostate cancer educators.

One Response

  1. I bet it’s 3 to 5 years since either Aggarwal or Small prescribed ketoconazole to a patient before abiraterone or enzalutamide.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s